Filing Details
- Accession Number:
- 0001628280-25-028896
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-06-02 19:26:09
- Reporting Period:
- 2025-05-30
- Filing Date:
- 2025-06-02
- Accepted Time:
- 2025-06-02 19:26:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1706431 | Vir Biotechnology Inc. | VIR | Biological Products, (No Disgnostic Substances) (2836) | 812730369 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1821008 | Janet Napolitano | C/O Vir Biotechnology, Inc. 1800 Owens Street, Suite 900 San Francisco CA 94158 | Yes | No | No | No |
Transaction Summary
| Sold: | 3,200 shares | Avg. Price: $5.05 | Total Value: $16,148.80 |
| Number of Shares After Transactions: | 16,416 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-05-30 | 8,000 | $0.00 | 19,616 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2025-06-02 | 3,200 | $5.05 | 16,416 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2025-05-30 | 16,000 | $0.00 | 16,000 | $4.94 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 16,000 | 2026-05-30 | 2035-05-29 | No | 4 | A | Direct |
Footnotes
- Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan.
- The RSUs will vest in full on May 30, 2026.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2024.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.845 to $5.15, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- The shares subject to the stock option will vest and become exercisable in full on May 30, 2026.
Billionaire Hedge Funds
